ARCHIVES

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Subcommittee Leaning Toward Mouse-Dog Drug Testing New Preclinical Toxicity-Protocol

July 20, 1979

Gori To Leave NCI For Job At Franklin Institute

April 18, 1980

In Brief: Switch To Grants Did Not hurt Virus Research, Watson says; The Field Is Healthy, Well Funded

October 2, 1981

Adamson Is Named Acting Deputy; Broder Begins Search For Roper Replacement

May 25, 1990

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

NCI CTEP: Approved Trials For The Month of October

October 28, 2011